Dr. Arup Chakraborty, PhD
Robert T. Haslam Professor in Chemical Engineering, Professor of Chemistry & Biological Engineering
Dr. Chakraborty got his PhD in chemical engineering at the University of Delaware as well as his postdoctoral studies at the University of Minnesota. Dr. Arup Chakraborty then joined the faculty at the University of California at Berkeley in December 1988. He also served as the Warren and Katherine Schlinger Distinguished Professor and Chair of Chemical Engineering, Chemistry, and Biophysics at Berkeley.
As a founding member of the Ragon Institute of MIT, MGH, and Harvard, Dr. Chakraborty is focused on multi-disciplinary approaches to understand human immunology. He has published several papers on immunology, specifically related to HIV and viral vulnerabilities. Some of his more notable works are “Coordinate linkage of HIV evolution reveals regions of immunological vulnerability” Proc Natl Acad Sci U S A 108, no. 28 (2011): 11530-5 and “Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design." Immunity 38, no. 3 (2013): 606-17.
In September 2005, Arup moved to MIT. Arup K. Chakraborty is the Robert T. Haslam Professor of Chemical Engineering, Chemistry, Physics, and Biological Engineering at MIT. He is the founding Director of MIT’s Institute of Medical Engineering and Science. He will be a Plenary speaker at the 13th US-Japan Drug Delivery Systems Symposium on Challenges and Opportunities in Vaccine Design and Delivery.
Ferguson, Andrew L., Jaclyn K. Mann, Saleha Omarjee, Thumbi Ndung'u, Bruce D. Walker, and Arup K. Chakraborty. "Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design." Immunity 38, no. 3 (2013): 606-17.
Dahirel, Vincent, Karthik Shekhar, Florencia Pereyra, Toshiyuki Miura, Mikita Artyomov, Sh Talsania, iv, Todd M. Allen, Marcus Altfeld, Mary Carrington, Darrell J. Irvine et al. "Coordinate linkage of HIV evolution reveals regions of immunological vulnerability." Proc Natl Acad Sci U S A 108, no. 28 (2011): 11530-5.
Kosmrlj, Andrej, Elizabeth L. Read, Ying Qi, Todd M. Allen, Marcus Altfeld, Steven G. Deeks, Florencia Pereyra, Mary Carrington, Bruce D. Walker, and Arup K. Chakraborty. "Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection." Nature 465, no. 7296 (2010): 350-4.
Das, Jayajit, Mary Ho, Julie Zikherman, Christopher Govern, Ming Yang, Arthur Weiss, Arup K. Chakraborty, and Jeroen P. Roose. "Digital signaling and hysteresis characterize ras activation in lymphoid cells." Cell 136, no. 2 (2009): 337-51.
Li, Qi-Jing, Aaron R. Dinner, Shuyan Qi, Darrell J. Irvine, Johannes B. Huppa, Mark M. Davis, and Arup K. Chakraborty. "CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse." Nat Immunol 5, no. 8 (2004): 791-9.
Prof. Steve Lippard PhD.
Multi-award Winning Professor to be Plenary Speaker at 13th US-Japan Drug Delivery Symposium
Prof. Stephen Lippard has been confirmed as a Plenary speaker at the Langer Labs 13th US-Japan Symposium On Drug Delivery Systems. Stephen Lippard will be speaking about Pt, Os, Re Anticancer Drugs: Delivery and Mechanism. Stephen Lippards is the Arthur Amos Noyes Professor of Chemistry at the Massachusetts Institute of Technology. Lippard is an extramural faculty member of MIT’s David H. Koch Institute for Integrative Cancer Research.
Lippard has studied biological interactions involving metal ions. He focused on reactions and properties of metal complexes. These complexes can be useful as drugs to treat cancers and as models for the metalloproteins active sites.
Lippard is well known in the industry for his work on the drug delivery mechanism of the anti-cancer drug cisplatin. His lab is currently working on designing more effective anti-tumor agent delivery systems.
The American Chemical Society interviewed Professor Lippard for their Voices of Inorganic Chemistry. Take a look and find out more about Stephen Lippard.
About Stephen Lippards accomplishments:
In 2006, professor Lippard received the National Medal of Science; the highest science honor in the USA and holds the 2009 Linus Pauling Medal. He has been elected into the National Academy of Sciences as well as the Institute of Medicine, and the American Academy. He has also received several awards from the American Chemical Society and his research has been recognized internationally. He was the inaugural co-recipient of the Christopher J. Frederickson Prize for Research in the Neurobiology of Zinc in 2012 for his work in metalloneurochemistry.
Lippard authored more than 800 articles in both professional and scholarly journals. He is the author of two textbooks, including “Principles of Bioinorganic Chemistry” with Jeremy M. Berg. In addition to his numerous awards and scholarly articles Lippard holds several patents both in the U.S. and foreign nations.
Recently Lippard co-founded Blend Therapeutics while he continues both his work at MIT and enjoying time with his two sons and twin granddaughters.